The Gut and Skin Microbiome in Vitiligo Disease Progression

Abroad (travel likely)Recruiting

Conditions

Vitiligo · Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Northwestern University, Chicago, Illinois, United States
Contact: Study coordinator (Dermatology CTU) · NUdermatologyCTU@northwestern.edu · 312-503-5944

Study leads

I. Caroline Le Poole
Principal Investigator
Northwestern University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

Healthy · Active Non-segmental Vitiligo · Severe Alopecia Areata

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

Nonsegmental Vitiligo

Abroad (travel likely)RecruitingPHASE2

Bryant, United States · Fountain Valley, United States

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

Vitiligo · Non-Segmental Vitiligo (NSV)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Phoenix, United States

A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY201 Tablets in Subjects With Non-Segmental Vitiligo

Adult Subjects With Non-Segmental Vitiligo

Abroad (travel likely)RecruitingPHASE2

Shenyang, China